{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T08:40:17Z","timestamp":1765356017811},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T00:00:00Z","timestamp":1452902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s11916-016-0542-3","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T19:03:21Z","timestamp":1452971001000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Chronic Daily Headache: Mechanisms and Principles of Management"],"prefix":"10.1007","volume":"20","author":[{"given":"Amy W.","family":"Voigt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Harry J.","family":"Gould","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,1,16]]},"reference":[{"key":"542_CR1","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.1989.03420150061038","volume":"261","author":"MS Linet","year":"1989","unstructured":"Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiologic study of headache among adolescents and young adults. JAMA. 1989;261:2211\u20136.","journal-title":"JAMA"},{"key":"542_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","volume":"41","author":"RB Lipton","year":"2001","unstructured":"Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646\u201357.","journal-title":"Headache"},{"key":"542_CR3","first-page":"247","volume-title":"Wolff\u2019s headache and other head pain","author":"SD Silberstein","year":"2001","unstructured":"Silberstein SD, Lipton RB. Chronic daily headache, including transformed migraine, chronic tension-type headache and medication overuse. In: Silberstein SD, Lipton RB, Dalessio DJ, editors. Wolff\u2019s headache and other head pain. 4th ed. New York: Oxford University Press; 2001. p. 247\u201382.","edition":"4"},{"key":"542_CR4","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1212\/WNL.0b013e3181974b19","volume":"72","author":"RB Lipton","year":"2009","unstructured":"Lipton RB. Tracing transformation: chronic migration classification, progression, and epidemiology. Neurology. 2009;72:S3\u20137.","journal-title":"Neurology"},{"key":"542_CR5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/23771003.1996.12314832","volume":"31","author":"NH Raskin","year":"1996","unstructured":"Raskin NH. Approach to the patient with migraine. Hosp Pract. 1996;31:93\u2013104.","journal-title":"Hosp Pract"},{"key":"542_CR6","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/head.12014","volume":"53","author":"RW Evans","year":"2013","unstructured":"Evans RW. A rational approach to the management of chronic migraine. Headache. 2013;53:168\u201376. This is an excellent review of current clinical approaches to treating chronic headaches in terms of medications, office procedures, surgical procedures and non-pharmacologic therapies.","journal-title":"Headache"},{"key":"542_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"MJ Marmura","year":"2015","unstructured":"Marmura MJ, Silberstein SD, Schwedt TJ. The acute treatment of migraine in adults: the American headache society evidence assessment of migraine pharmacotherapies. Headache. 2015;55:3\u201320.","journal-title":"Headache"},{"key":"542_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pain.2006.01.016","volume":"122","author":"SK Afridi","year":"2006","unstructured":"Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes: prolonged effects from a single injection. Pain. 2006;122:126\u20139.","journal-title":"Pain"},{"key":"542_CR9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1212\/01.wnl.0000311390.87642.d8","volume":"70","author":"M Naumann","year":"2008","unstructured":"Naumann M, So Y, Argoff CE, Childers MK, Dykstra DD, Gronseth GS, et al. Therapeutics and technology assessment subcommittee of the American Academy of Neurology. Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the American academy of neurology. Neurology. 2008;70:1707\u201314.","journal-title":"Neurology"},{"key":"542_CR10","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1111\/j.1526-4610.2008.01192.x","volume":"48","author":"WB Young","year":"2008","unstructured":"Young WB, Marmura M, Ashkenazi A, Evans RW. Expert opinion: greater occipital nerve and other anesthetic injections for primary headache disorders. Headache. 2008;48:1122\u20135.","journal-title":"Headache"},{"key":"542_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1526-4610.1994.hed3409497.x","volume":"34","author":"JR Saper","year":"1994","unstructured":"Saper JR, Silberstein SD, Lake III AE, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34:497\u2013502.","journal-title":"Headache"},{"key":"542_CR12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1046\/j.1526-4610.2002.02125.x","volume":"42","author":"AV Krymchantowski","year":"2002","unstructured":"Krymchantowski AV, Silva MT, Barbosa JS, Alves LA. Amitriptyline versus amitriptyline combined with fluoxetine in the preventative treatment of transformed migraine: a double-blind study. Headache. 2002;42:510\u20134.","journal-title":"Headache"},{"key":"542_CR13","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/WNF.0b013e3181a8c84f","volume":"32","author":"S Tarlaci","year":"2009","unstructured":"Tarlaci S. Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol. 2009;32:254\u20138.","journal-title":"Clin Neuropharmacol"},{"key":"542_CR14","unstructured":"Hain TC, Cherchi M. Migraine headache: prevention. Dizziness-and-balance.com. 2015; http:\/\/www.dizziness-and-balance.com\/disorders\/central\/migraine\/migraine%20prevention.html ."},{"key":"542_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1526-4610.1991.hed3102071.x","volume":"31","author":"NT Mathew","year":"1991","unstructured":"Mathew NT, Ali S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache. 1991;31:71\u20134.","journal-title":"Headache"},{"key":"542_CR16","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1212\/01.WNL.0000100121.58594.11","volume":"61","author":"PJ Spira","year":"2003","unstructured":"Spira PJ, Beran RG. Australian gabapentin chronic daily headache group. Gabapentin in the prophylaxis of chronic daily headache: a randomized, placebo-controlled study. Neurology. 2003;61:1753\u20139.","journal-title":"Neurology"},{"key":"542_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.curtheres.2005.06.006","volume":"66","author":"AM Rapoport","year":"2005","unstructured":"Rapoport AM, Sheftell FD, Tepper SJ, Bigal M. Levetiracetam in the preventive treatment of transformed migraine. Curr Ther Res. 2005;66:212\u201321.","journal-title":"Curr Ther Res"},{"key":"542_CR18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1185\/030079906X104731","volume":"22","author":"SD Silberstein","year":"2006","unstructured":"Silberstein SD, Loder E, Forde G, Papadopoulos G, Fairclough D, Greenberg S. The impact of migraine on daily activities: effect of topiramate compared with placebo. Curr Med Res Opin. 2006;22:1021\u20139.","journal-title":"Curr Med Res Opin"},{"key":"542_CR19","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1526-4610.2006.00684.x","volume":"47","author":"SD Silberstein","year":"2007","unstructured":"Silberstein SD, Lipton RB, Dodick DW, Topiramate Chronic Migraine Study Group, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007;47:170\u201380.","journal-title":"Headache"},{"key":"542_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1468-2982.2007.01326.x","volume":"27","author":"HC Diener","year":"2007","unstructured":"Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. TOPMAT-MIG-201(TOP-CHROME) Study Group. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007;27:814\u201323.","journal-title":"Cephalalgia"},{"key":"542_CR21","first-page":"CD003225","volume":"2","author":"K Linde","year":"2004","unstructured":"Linde K, Rossnagel K. Propranolol for migraine prophylaxis. Cochrane Database Syst Rev. 2004;2:CD003225.","journal-title":"Cochrane Database Syst Rev"},{"key":"542_CR22","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.tips.2006.06.003","volume":"27","author":"SD Silberstein","year":"2006","unstructured":"Silberstein SD. Preventive treatment of migraine. Trends Pharmacol Sci. 2006;27:410\u20135.","journal-title":"Trends Pharmacol Sci"},{"key":"542_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.4103\/0253-7613.93840","volume":"44","author":"R Nandha","year":"2012","unstructured":"Nandha R, Singh H. Renin angiotensin system: a novel target for migraine prophylaxis. Indian J Pharm. 2012;44:157\u201360.","journal-title":"Indian J Pharm"},{"key":"542_CR24","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","volume":"78","author":"SD Silberstein","year":"2012","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Quality standards subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1337\u201345. This report provides a comprehensive analysis of published studies from 1999 to 2009 that looked at class I and II articles that listed level A evidence of efficacy for medications used for the prevention of episodic migraine. Guidelines are provided for the use of medications that ideally decrease the frequency and severity of migraine attack, thereby reducing medication overuse and the potential transition to chronic headaches.","journal-title":"Neurology"},{"key":"542_CR25","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1046\/j.1526-4610.2002.02122.x","volume":"42","author":"JR Saper","year":"2002","unstructured":"Saper JR, Lake III AE, Cantrell DT, Winner PK, White JR. Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study. Headache. 2002;42:470\u201382.","journal-title":"Headache"},{"key":"542_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1185\/174234306X112844","volume":"3","author":"SJ Tepper","year":"2006","unstructured":"Tepper SJ, Bigal M, Rapoport A, Sheftell F. Alternative therapies: evidence based evaluation in migraine. Headache Care. 2006;3:57\u201364.","journal-title":"Headache Care"},{"key":"542_CR27","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","volume":"78","author":"S Holland","year":"2012","unstructured":"Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E. Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012;78:1346\u201353.","journal-title":"Neurology"},{"key":"542_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1055\/s-0030-1249224","volume":"30","author":"I Garza","year":"2010","unstructured":"Garza I, Schwedt TJ. Diagnosis and management of chronic daily headache. Semin Neurol. 2010;30:154\u201366.","journal-title":"Semin Neurol"},{"key":"542_CR29","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1212\/01.wnl.0000325565.63526.d2","volume":"71","author":"ME Bigal","year":"2008","unstructured":"Bigal ME, Lipton RB. Clinical course in migraine: conceptualizing migraine transformation. Neurology. 2008;71:848\u201355.","journal-title":"Neurology"},{"key":"542_CR30","doi-asserted-by":"crossref","unstructured":"Kandasamy R, Price TJ. The pharmacology of nociceptor priming. In: Shaible H-G, editor. Pain Control, Handbook of Exper Pharmacol. 2015;227:15\u201337.","DOI":"10.1007\/978-3-662-46450-2_2"},{"key":"542_CR31","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1468-2982.2004.00691.x","volume":"24","author":"ME Bigal","year":"2004","unstructured":"Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre\u2014clinical characteristics and treatment outcomes. Cephalalgia. 2004;24:483\u201390.","journal-title":"Cephalalgia"},{"key":"542_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1177\/0333102412467512","volume":"33","author":"JL Johnson","year":"2012","unstructured":"Johnson JL, Hutchinson MR, Williams DB. Medication-overuse headache and opioid-induced hyperalgesia: a review of mechanisms, a neuroimmune hypothesis and a novel approach to treatment. Cephalalgia. 2012;33:52\u201364.","journal-title":"Cephalalgia"},{"key":"542_CR33","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1100\/tsw.2007.230","volume":"7","author":"MR Hutchinson","year":"2007","unstructured":"Hutchinson MR, Bland ST, Johnson KW, Rice KC, Maier SF, Watkins LR. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Sci World J. 2007;7:98\u2013111.","journal-title":"Sci World J"},{"key":"542_CR34","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.bbi.2008.07.008","volume":"22","author":"MR Hutchinson","year":"2008","unstructured":"Hutchinson MR, Northcutt AL, Chao LW, Kearney JJ, Zhang Y, Berkelhammer DL, et al. Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia. Brain Behav Immun. 2008;22:1248\u201356.","journal-title":"Brain Behav Immun"},{"key":"542_CR35","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/j.1526-4610.2007.00907.x","volume":"47","author":"ID Meng","year":"2007","unstructured":"Meng ID, Cao L. From migraine to chronic daily headache: the biological basis of headache transformation. Headache. 2007;47:1251\u20138.","journal-title":"Headache"},{"key":"542_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nrn2533","volume":"10","author":"E Milligan","year":"2009","unstructured":"Milligan E, Watkins L. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci. 2009;10:23\u201336.","journal-title":"Nat Rev Neurosci"},{"key":"542_CR37","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","volume":"30","author":"LR Watkins","year":"2009","unstructured":"Watkins LR, Hutchinson MR, Rice KC, Maier SF. The \u201ctoll\u201d of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci. 2009;30:581\u201391.","journal-title":"Trends Pharmacol Sci"},{"key":"542_CR38","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1526-4610.2007.00854.x","volume":"47","author":"S Thalakoti","year":"2007","unstructured":"Thalakoti S, Patil VV, Damodaram S, Vause CV, Langford LE, Freeman SE, et al. Neuron-glia signaling in trigeminal ganglion: implications for migraine pathology. Headache. 2007;47:1008\u201323.","journal-title":"Headache"},{"key":"542_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/00002826-199510000-00002","volume":"18","author":"H Ollat","year":"1995","unstructured":"Ollat H, Cesaro P. Pharmacology of neuropathic pain. Clin Neuropharmacol. 1995;18:391\u2013404.","journal-title":"Clin Neuropharmacol"},{"key":"542_CR40","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10540-005-2742-7","volume":"24","author":"ER Kandel","year":"2004","unstructured":"Kandel ER. The molecular biology of memory storage: a dialog between genes and synapses. Biosci Rep. 2004;24:475\u2013522.","journal-title":"Biosci Rep"},{"key":"542_CR41","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s12264-012-1204-z","volume":"28","author":"YX Tao","year":"2012","unstructured":"Tao YX. AMPA receptor trafficking in inflammation-induced dorsal horn central sensitization. Neurosci Bull. 2012;28:111\u201320.","journal-title":"Neurosci Bull"},{"key":"542_CR42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1744-8069-9-6","volume":"9","author":"TJ Price","year":"2013","unstructured":"Price TJ, Ghosh S. ZIPping to pain relief: the role (or not) of PKM\u03b6 in chronic pain. Mol Pain. 2013;9:6.","journal-title":"Mol Pain"},{"key":"542_CR43","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/bs.pmbts.2014.11.010","volume":"131","author":"TJ Price","year":"2015","unstructured":"Price TJ, Inyang KE. Commonalities between pain and memory mechanisms and their meaning for understanding chronic pain. Prog Mol Biol Transl Sci. 2015;131:409\u201334.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"542_CR44","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pain.2005.02.009","volume":"115","author":"A Ledeboer","year":"2005","unstructured":"Ledeboer A, Sloane EM, Milligan ED, Frank MG, Mahony JH, Maier SF, et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain. 2005;115:71\u201383.","journal-title":"Pain"},{"key":"542_CR45","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","volume":"24","author":"MR Hutchinson","year":"2010","unstructured":"Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24:83\u201395.","journal-title":"Brain Behav Immun"},{"key":"542_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1017\/S1740925X0700035X","volume":"2","author":"A Ledeboer","year":"2006","unstructured":"Ledeboer A, Liu T, Shumilla JA, Mahoney JH, Vijay S, Gross MI, et al. The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol. 2006;2:279\u201391.","journal-title":"Neuron Glia Biol"},{"key":"542_CR47","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1517\/14656560903426189","volume":"10","author":"P Rolan","year":"2009","unstructured":"Rolan P, Hutchinson M, Johnson K. Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease. Expert Opin Pharmacother. 2009;10:2897\u2013904.","journal-title":"Expert Opin Pharmacother"},{"key":"542_CR48","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1212\/WNL.0b013e3181d7d651","volume":"74","author":"F Barkhof","year":"2010","unstructured":"Barkhof F, Hulst HE, Drulovic J, Uitdehaag BM, Matsuda K, Landin R. MN166-001 investigators. Ibudilast in relapsing-remitting multiple sclerosis: a neuroprotectant? Neurology. 2010;74:1033\u201340.","journal-title":"Neurology"},{"key":"542_CR49","first-page":"243","volume":"5","author":"Z Volfe","year":"1985","unstructured":"Volfe Z, Dvilansky A, Nathan I. Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients. Int J Clin Pharmacol Res. 1985;5:243\u20136.","journal-title":"Int J Clin Pharmacol Res"},{"key":"542_CR50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/TCRM.S1928","volume":"4","author":"EB Russo","year":"2008","unstructured":"Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008;4:245\u201359.","journal-title":"Ther Clin Risk Manag"},{"key":"542_CR51","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/head.12570","volume":"55","author":"EP Baron","year":"2015","unstructured":"Baron EP. Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it\u2019s been \u2026. Headache. 2015;55:885\u2013916.","journal-title":"Headache"},{"key":"542_CR52","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1038\/nrd1251","volume":"2","author":"L Watkins","year":"2003","unstructured":"Watkins L, Glia MS. A novel drug discovery target for clinical pain. Nat Rev Drug Discov. 2003;2:973\u201385.","journal-title":"Nat Rev Drug Discov"},{"key":"542_CR53","first-page":"317","volume":"26","author":"WJ Vanast","year":"1986","unstructured":"Vanast WJ. New daily persistent headaches: definition of a benign syndrome. Headache. 1986;26:317.","journal-title":"Headache"},{"key":"542_CR54","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0140-6736(87)90119-X","volume":"1","author":"F Diaz-Mitoma","year":"1987","unstructured":"Diaz-Mitoma F, Vanast WJ, Tyrrell DL. Increased frequency of Epstein-Barr virus excretion in patients with new daily persistent headaches. Lancet. 1987;1:411\u20135.","journal-title":"Lancet"},{"key":"542_CR55","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2169\/internalmedicine1962.30.161","volume":"30","author":"T Hamada","year":"1991","unstructured":"Hamada T, Ohshima K, Ide Y, Sakato S, Takamori M. A case of new daily persistent headache with elevated antibodies to Epstein-Barr virus. Jpn J Med. 1991;30:161\u20133.","journal-title":"Jpn J Med"},{"key":"542_CR56","doi-asserted-by":"publisher","first-page":"530","DOI":"10.2169\/internalmedicine.32.530","volume":"32","author":"JR Santoni","year":"1993","unstructured":"Santoni JR, Santoni-Williams CJ. Headache and painful lymphadenopathy in extracranial or systemic infection: etiology of new daily persistent headaches. Intern Med. 1993;32:530\u20132.","journal-title":"Intern Med"},{"key":"542_CR57","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1046\/j.1468-2982.2002.00326.x","volume":"22","author":"D Li","year":"2002","unstructured":"Li D, Rozen TD. The clinical characteristics of new daily persistent headache. Cephalalgia. 2002;22:66\u20139.","journal-title":"Cephalalgia"},{"key":"542_CR58","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1111\/j.1468-2982.2004.00771.x","volume":"24","author":"Y Takase","year":"2004","unstructured":"Takase Y, Nakano M, Tatsumi C, Matsuyama T. Clinical features, effectiveness of drug-based treatment, and prognosis of new daily persistent headache (NDPH): 30 cases in Japan. Cephalalgia. 2004;24:955\u20139.","journal-title":"Cephalalgia"},{"key":"542_CR59","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11916-003-0076-3","volume":"7","author":"TD Rozen","year":"2003","unstructured":"Rozen TD. New daily persistent headache. Curr Pain Headache Rep. 2003;7:218\u201323.","journal-title":"Curr Pain Headache Rep"},{"key":"542_CR60","first-page":"209","volume-title":"Chronic daily headache for clinicians","author":"TD Rozen","year":"2005","unstructured":"Rozen TD. New daily persistent headache. In: Goadsby PJ, Dodick DW, editors. Chronic daily headache for clinicians. 1st ed. Hamilton, Ontario: BC Decker Inc; 2005. p. 209\u201315.","edition":"1"},{"key":"542_CR61","first-page":"1118","volume":"21","author":"RB Lipton","year":"2015","unstructured":"Lipton RB. Risk factors for and management of medication-over use headache. Continuum (Minneap Minn). 2015;21:1118\u201331. This review compares MOH (a secondary headache disorder) to chronic daily headache, and provides guidelines to help the practitioner manage and reduce the risk of medication-overuse headache and limit the development of chronic daily headache.","journal-title":"Continuum (Minneap Minn)"},{"key":"542_CR62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1046\/j.1526-4610.2000.00032.x","volume":"40","author":"JC Krusz","year":"2000","unstructured":"Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40:224\u201330.","journal-title":"Headache"},{"key":"542_CR63","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11916-006-0009-z","volume":"10","author":"JC Krusz","year":"2006","unstructured":"Krusz JC. Intravenous treatment of chronic daily headaches in the outpatient headache clinic. Curr Pain Headache Rep. 2006;10:47\u201353.","journal-title":"Curr Pain Headache Rep"},{"key":"542_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11940-007-0033-2","volume":"9","author":"HJ Gould III","year":"2007","unstructured":"Gould III HJ. Management of painful neuropathies. Curr Treat Options Neurol. 2007;9:75\u201384.","journal-title":"Curr Treat Options Neurol"},{"key":"542_CR65","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1586\/14737175.7.9.1145","volume":"7","author":"M Obermann","year":"2007","unstructured":"Obermann M, Katsarava Z. Management of medication-overuse headache. Expert Rev Neurother. 2007;7:1145\u201355.","journal-title":"Expert Rev Neurother"},{"key":"542_CR66","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1526-4610.1990.hed3010634.x","volume":"30","author":"NT Mathew","year":"1990","unstructured":"Mathew NT, Kurman R, Perez F. Drug induced refractory headache\u2014clinical features and management. Headache. 1990;30:634\u20138.","journal-title":"Headache"},{"key":"542_CR67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11916-006-0042-y","volume":"10","author":"DM Biondi","year":"2006","unstructured":"Biondi DM. Is migraine a neuropathic pain syndrome? Curr Pain Headache Rep. 2006;10:167\u201378.","journal-title":"Curr Pain Headache Rep"},{"key":"542_CR68","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/0166-2236(91)90024-O","volume":"14","author":"CJ Woolf","year":"1991","unstructured":"Woolf CJ, Walters ET. Common patterns of plasticity contributing to nociceptive sensitization in mammals and Aplysia. Trends Neurosci. 1991;14:74\u20138.","journal-title":"Trends Neurosci"},{"key":"542_CR69","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1113\/jphysiol.1973.sp010273","volume":"232","author":"TV Bliss","year":"1973","unstructured":"Bliss TV, Lomo T. Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol. 1973;232:331\u201356.","journal-title":"J Physiol"},{"key":"542_CR70","first-page":"428","volume-title":"The biochemical basis of neuropharmacology","author":"JR Cooper","year":"1991","unstructured":"Cooper JR, Bloom FE, Roth RH. The biochemical basis of neuropharmacology. 6th ed. New York: Oxford University Press; 1991. p. 428\u201346.","edition":"6"},{"key":"542_CR71","volume-title":"The organization of behavior","author":"DO Hebb","year":"1949","unstructured":"Hebb DO. The organization of behavior. NY: Wiley (Interscience); 1949."},{"key":"542_CR72","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.tins.2003.09.017","volume":"26","author":"RR Ji","year":"2003","unstructured":"Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26:696\u2013705.","journal-title":"Trends Neurosci"},{"key":"542_CR73","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jpain.2009.06.012","volume":"10","author":"A Latremoliere","year":"2009","unstructured":"Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10:895\u2013926.","journal-title":"J Pain"},{"key":"542_CR74","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1097\/01.anes.0000264769.87038.55","volume":"106","author":"CJ Woolf","year":"2007","unstructured":"Woolf CJ. Central sensitization: uncovering the relation between pain and plasticity. Anesthesiology. 2007;106:864\u20137.","journal-title":"Anesthesiology"},{"key":"542_CR75","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.tins.2009.07.007","volume":"32","author":"DB Reichling","year":"2009","unstructured":"Reichling DB, Levine JD. Critical role of nociceptor plasticity in chronic pain. Trends Neurosci. 2009;32:611\u20138.","journal-title":"Trends Neurosci"},{"key":"542_CR76","volume-title":"Conditional reflexes","author":"IP Pavlov","year":"1927","unstructured":"Pavlov IP. Conditional reflexes. London: Oxford University Press; 1927."},{"key":"542_CR77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02964534","volume":"24","author":"G Windholz","year":"1989","unstructured":"Windholz G. The discovery of the principles of reinforcement, extinction, generalization, and differentiation of conditional reflexes in Pavlov\u2019s laboratories. Pavlov J Biol Sci. 1989;24:35\u201342.","journal-title":"Pavlov J Biol Sci"},{"key":"542_CR78","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.neuroscience.2010.04.082","volume":"169","author":"EK Joseph","year":"2010","unstructured":"Joseph EK, Levine JD. Hyperalgesic priming is restricted to isolectin B4-positive nociceptors. Neuroscience. 2010;169:431\u20135.","journal-title":"Neuroscience"},{"key":"542_CR79","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1523\/JNEUROSCI.0256-08.2008","volume":"28","author":"SG Khasar","year":"2008","unstructured":"Khasar SG, Burkham J, Dina OA, Brown AS, Bogen O, Alessandri-Haber N, et al. Stress induces a switch of intracellular signaling in sensory neurons in a model of generalized pain. J Neurosci. 2008;28:5721\u201330.","journal-title":"J Neurosci"},{"key":"542_CR80","doi-asserted-by":"publisher","first-page":"4660","DOI":"10.1523\/JNEUROSCI.5530-09.2010","volume":"30","author":"EK Joseph","year":"2010","unstructured":"Joseph EK, Reichling DB, Levine JD. Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci. 2010;30:4660\u20136.","journal-title":"J Neurosci"},{"key":"542_CR81","doi-asserted-by":"publisher","first-page":"15113","DOI":"10.1523\/JNEUROSCI.3947-10.2010","volume":"30","author":"OK Melemedjian","year":"2010","unstructured":"Melemedjian OK, Asiedu MN, Tillu DV, Peebles KA, Yan J, Ertz N, et al. IL-6- and NGF-induced rapid control of protein synthesis and nociceptive plasticity via convergent signaling to the eIF4F complex. J Neurosci. 2010;30:15113\u201323.","journal-title":"J Neurosci"},{"key":"542_CR82","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1744-8069-7-70","volume":"7","author":"OK Melemedjian","year":"2011","unstructured":"Melemedjian OK, Asiedu MN, Tillu DV, Sanoja R, Yan J, Lark A, et al. Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol Pain. 2011;7:70.","journal-title":"Mol Pain"},{"key":"542_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1744-8069-9-12","volume":"9","author":"OK Melemedjian","year":"2013","unstructured":"Melemedjian OK, Tillu DV, Asiedu MN, Mandell EK, Moy JK, Blute VM, et al. BDNF regulates atypical PKC at spinal synapses to initiate and maintain a centralized chronic pain state. Mol Pain. 2013;9:12.","journal-title":"Mol Pain"},{"issue":"Pt A","key":"542_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neulet.2013.06.060","volume":"557","author":"TJ Price","year":"2013","unstructured":"Price TJ, Dussor GAMPK. An emerging target for modification of injury-induced pain plasticity. Neurosci Lett. 2013;557(Pt A):9\u201318.","journal-title":"Neurosci Lett"},{"key":"542_CR85","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jpain.2013.05.012","volume":"14","author":"OQ Russe","year":"2013","unstructured":"Russe OQ, M\u00f6ser CV, Kynast KL, King TS, Stephan H, Geisslinger G, et al. Activation of the AMP-activated protein kinase reduces inflammatory nociception. J Pain. 2013;14:1330\u201340.","journal-title":"J Pain"},{"key":"542_CR86","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.neuron.2008.10.004","volume":"60","author":"GJ Bassell","year":"2008","unstructured":"Bassell GJ, Warren ST. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron. 2008;60:201\u201314.","journal-title":"Neuron"},{"key":"542_CR87","doi-asserted-by":"publisher","first-page":"11002","DOI":"10.1523\/JNEUROSCI.1785-13.2013","volume":"33","author":"LF Ferrari","year":"2013","unstructured":"Ferrari LF, Bogen O, Levine JD. Role of nociceptor \u03b1CaMKII in transition from acute to chronic pain (hyperalgesic priming) in male and female rats. J Neurosci. 2013;33:11002\u201311.","journal-title":"J Neurosci"},{"key":"542_CR88","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/01.aco.0000432511.08070.de","volume":"26","author":"C Rivat","year":"2013","unstructured":"Rivat C, Bollag L, Richeb\u00e9 P. Mechanisms of regional anaesthesia protection against hyperalgesia and pain chronicization. Curr Opin Anaesthesiol. 2013;26:621\u20135.","journal-title":"Curr Opin Anaesthesiol"},{"key":"542_CR89","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1468-2982.2006.01191.x","volume":"26","author":"A Ashkenazi","year":"2006","unstructured":"Ashkenazi A, Benlifer A, Korenblit J, Silberstein SD. Zonisamide for migraine prophylaxis in refractory patients. Cephalalgia. 2006;26:1199\u2013202.","journal-title":"Cephalalgia"},{"key":"542_CR90","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1111\/j.1526-4610.2007.01016.x","volume":"48","author":"K Spengos","year":"2008","unstructured":"Spengos K, Theleritis C, Paparrigopoulos T. Memantine and NMDA antagonism for chronic migraine: a potentially novel therapeutic approach? Headache. 2008;48:284\u20136.","journal-title":"Headache"},{"key":"542_CR91","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/j.1526-4610.2008.01083.x","volume":"48","author":"M Bigal","year":"2008","unstructured":"Bigal M, Rapoport A, Sheftell F, Tepper D, Tepper S. Memantine in the preventive treatment of refractory migraine. Headache. 2008;48:1337\u201342.","journal-title":"Headache"},{"key":"542_CR92","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.lfs.2006.05.023","volume":"79","author":"ZJ Wang","year":"2006","unstructured":"Wang ZJ, Wang LX. Phosphorylation: a molecular switch in opioid tolerance. Life Sci. 2006;79:1681\u201391.","journal-title":"Life Sci"},{"issue":"277","key":"542_CR93","first-page":"1","volume":"8","author":"JS Cavallo","year":"2014","unstructured":"Cavallo JS, Hamilton BN, Farley J. Behavioral and neural bases of extinction learning in Hermissenda. Front Behav Neurosci. 2014;8(277):1\u201317.","journal-title":"Front Behav Neurosci"},{"issue":"354","key":"542_CR94","first-page":"1","volume":"8","author":"JS Cavallo","year":"2014","unstructured":"Cavallo JS, Hamilton BN, Farley J. In vitro extinction learning in Hermissenda: involvement of conditioned inhibition molecules. Front Behav Neurosci. 2014;8(354):1\u201324.","journal-title":"Front Behav Neurosci"},{"key":"542_CR95","doi-asserted-by":"publisher","unstructured":"H\u00fcllemann P, Shao YQ, Manthey G, Binder A, Baron R. Central habituation and distraction alter C-fibre-mediated laser-evoked potential amplitudes. Eur J Pain. 2015. doi: 10.1002\/ejp.735 .","DOI":"10.1002\/ejp.735"},{"key":"542_CR96","first-page":"29","volume":"15","author":"CN Shealy","year":"2015","unstructured":"Shealy CN. Guided imagery, mindful meditation, and hypnosis for pain management. Pract Pain Manage. 2015;15:29\u201334.","journal-title":"Pract Pain Manage"},{"issue":"158","key":"542_CR97","first-page":"1","volume":"16","author":"EG Trevelyan","year":"2015","unstructured":"Trevelyan EG, Turner WA, Robinson N. Acupuncture for the treatment of phantom limb pain in lower limb amputees: study protocol for a randomized controlled feasibility trial. Trials. 2015;16(158):1\u20138.","journal-title":"Trials"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0542-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11916-016-0542-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0542-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-016-0542-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T20:57:48Z","timestamp":1718312268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11916-016-0542-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,16]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s11916-016-0542-3","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,16]]},"assertion":[{"value":"16 January 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Amy W. Voigt and Harry J. Gould III declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"10"}}